INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 216 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,140,000 | -19.7% | 159,284 | +4.0% | 0.01% | -12.5% |
| Q2 2021 | $1,420,000 | +3.4% | 153,222 | +3.6% | 0.01% | -11.1% |
| Q1 2021 | $1,373,000 | +0.7% | 147,950 | -4.0% | 0.01% | 0.0% |
| Q4 2020 | $1,364,000 | -11.0% | 154,113 | +16.6% | 0.01% | -18.2% |
| Q3 2020 | $1,533,000 | -28.9% | 132,147 | -77.1% | 0.01% | -38.9% |
| Q1 2019 | $2,156,000 | -6.7% | 578,013 | +0.1% | 0.02% | -10.0% |
| Q4 2018 | $2,311,000 | -17.7% | 577,634 | +14.4% | 0.02% | +11.1% |
| Q3 2018 | $2,807,000 | +42.0% | 504,818 | +0.1% | 0.02% | +38.5% |
| Q2 2018 | $1,977,000 | -16.8% | 504,426 | -0.1% | 0.01% | +116.7% |
| Q1 2018 | $2,375,000 | -2.2% | 504,709 | +90.8% | 0.01% | 0.0% |
| Q4 2014 | $2,428,000 | +8.5% | 264,470 | +16.4% | 0.01% | +20.0% |
| Q3 2014 | $2,238,000 | – | 227,185 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |